Lv22
186 积分 2024-05-28 加入
Incorporating Pharmacological Target-Mediated Drug Disposition (TMDD) in a Whole-Body Physiologically Based Pharmacokinetic (PBPK) Model of Linagliptin in Rat and Scale-up to Human
1天前
待确认
Scientific white paper on concentration-QTc modeling
23天前
已完结
Development and validation of LC-MS/MS method for simultaneous determination of dabigatran etexilate and its active metabolites in human plasma, and its application in a pharmacokinetic study
27天前
已完结
Daring to dream: Targeting lipoprotein(a) as a causal and risk-enhancing factor
1个月前
已完结
Oral agents for lowering lipoprotein(a)
1个月前
已完结
IcoSema: unveiling the future of diabetes management from a clinical pharmacology perspective
2个月前
已完结
Effect of Hepatic Impairment on the Pharmacokinetics and Pharmacodynamics of SHR4640, a Selective Human Urate Transporter 1 Inhibitor
2个月前
已完结
Frequent questions and responses on the 2022 lipoprotein(a) consensus statement of the European Atherosclerosis Society
3个月前
已完结
Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials
3个月前
已完结
Pharmacokinetics–Pharmacodynamics Modeling for Evaluating Drug–Drug Interactions in Polypharmacy: Development and Challenges
3个月前
已完结
皖公网安备34019202002308
